Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging

被引:29
|
作者
Wray, Patrick S. [1 ]
Clarke, Graham S. [2 ]
Kazarian, Sergei G. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England
[2] Bristol Myers Squibb Co, Wirral CH46 1QW, Merseyside, England
基金
英国工程与自然科学研究理事会;
关键词
Chemical imaging; Drug release; Tablet dissolution; Infrared; FT-IR spectroscopy; EXPLOSION SYSTEM TES; DRY-COATED TABLETS; DRUG-DELIVERY; GEL-LAYER; RELEASE; COMPACTION; PHOTOGRAPHY; MATRICES;
D O I
10.1016/j.ejps.2012.12.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work uses ATR-FTIR spectroscopic imaging to study the dissolution of delayed release and pH resistant compressed coating pharmaceutical tablets. Tablets with an inner core and outer shell were constructed using a custom designed compaction cell. The core of the delayed release tablets consisted of hydroxypropyl methylcellulose (HPMC) and caffeine. The shell consisted of microcrystalline cellulose (MCC) and glucose. The core of the pH resistant formulations was an ibuprofen and PEG melt and the shell was constructed from HPMC and a basic buffer. UV/vis spectroscopy was used to monitor the lag-time of drug release and visible optical video imaging was used as a complementary imaging technique with a larger field of view. Two delayed release mechanisms were established. For tablets with soluble shell sections, lag-time was dependent upon rapid shell dissolution. For tablets with less soluble shells, the lag-time was controlled by the rate of dissolution medium ingress through, the shell and the subsequent expansion of the wet HPMC core. The pH resistant formulations prevented crystallization of the ibuprofen in the core during dissolution despite an acidic dissolution medium. FTIR imaging produced important information about the physical and chemical processes occurring at the interface between tablet sections during dissolution. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:748 / 757
页数:10
相关论文
共 50 条
  • [21] INTRINSIC DISSOLUTION RATES OF TABLET FILLER-BINDERS AND THEIR INFLUENCE ON THE DISSOLUTION OF DRUGS FROM TABLET FORMULATIONS
    KOPARKAR, AD
    AUGSBURGER, LL
    SHANGRAW, RF
    PHARMACEUTICAL RESEARCH, 1990, 7 (01) : 80 - 86
  • [22] Microstructure-based mathematical modelling and spectroscopic imaging of tablet dissolution
    Kimber, James A.
    Kazarian, Sergei G.
    Stepanek, Frantisek
    COMPUTERS & CHEMICAL ENGINEERING, 2011, 35 (07) : 1328 - 1339
  • [23] Study of Petroleum Heat-exchanger Deposits with ATR-FTIR Spectroscopic Imaging
    Tay, Feng H.
    Kazarian, Sergei G.
    ENERGY & FUELS, 2009, 23 (08) : 4059 - 4067
  • [24] The effect of isoflurane on erythrocyte membranes studied by ATR-FTIR
    Gattoni, M
    Boffi, A
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1613 (1-2): : 72 - 78
  • [25] ATR-FTIR imaging of albumen photographic prints
    Ricci, Camilla
    Bloxham, Simon
    Kazarian, Sergei G.
    JOURNAL OF CULTURAL HERITAGE, 2007, 8 (04) : 387 - 395
  • [26] Magnetic resonance imaging of tablet dissolution
    Nott, Kevin P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (01) : 78 - 83
  • [27] A Diamond ATR-FTIR Study of Various Medicinal Cannabinoid Formulations
    Berets, Susan
    Christenson, Jeffrey
    SPECTROSCOPY, 2018, : 15 - 15
  • [28] Micro ATR-FTIR spectroscopic imaging of colon biopsies with a large area Ge crystal
    Song, Cai Li
    Kazarian, Sergei G.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2020, 228
  • [29] ATR-FTIR spectroscopy and spectroscopic imaging of solvent and permeant diffusion across model membranes
    McAuley, W. J.
    Lad, M. D.
    Mader, K. T.
    Santos, P.
    Tetteh, J.
    Kazarian, S. G.
    Hadgraft, J.
    Lane, M. E.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (02) : 413 - 419
  • [30] Applications of Fourier transform infrared spectroscopic imaging to tablet dissolution and drug release
    Kazarian, Sergei G.
    Ewing, Andrew V.
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (09) : 1207 - 1221